http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H04230220-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5022bf83b1b194e31270d3df208a747d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C35-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-117
filingDate 1991-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b47d73ce00186472ff29e00290f7b021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_827b3a09b97f1c49953d1c6049e4e4bf
publicationDate 1992-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H04230220-A
titleOfInvention Pharmaceutical composition
abstract PURPOSE: To obtain a pharmaceutical composition suitable for the prevention and treatment of diseases of cardiovascular system, kidney and cerebral region. n CONSTITUTION: This pharmaceutical composition for normalizing the abnormal level of neuropeptide Y (NPY) contains at least one kind of isomer of inositol triphosphate (IP 3 ) as an NPY-antagonistic agent. n COPYRIGHT: (C)1992,JPO
priorityDate 1990-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H02191218-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H02191220-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6310727-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H02191221-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14389199
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552692
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12068910
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426344400
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226502262
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID55310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44351041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226502261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226501542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57473858

Total number of triples: 38.